一个新的细菌RNA聚合酶抑制剂类别影响核酸添加
Irina Artsimovitch1, Clement Chu, A Simon Lynch
1Department of Bacteriology, University of Wisconsin, Madison, WI 53706, USA.
概括
新的细菌RNA聚合酶 (RNAP) 抑制剂揭示了酶的核酸添加循环机制. 这些化合物通过影响RNAP活性部位运动来全质地阻断催化.
科学领域:
- 分子生物学分子生物学
- 酶学 是一种酶学.
- 生物化学 生物化学
背景情况:
- RNA聚合酶 (RNAP) 对于基因表达至关重要.
- 尽管有现有的结构数据,但RNAP核酸添加周期的精确机制尚未完全理解.
研究的目的:
- 阐明细菌RNA聚合酶的核酸添加循环机制.
- 描述新型细菌RNA聚合酶抑制剂 (CBR703系列) 及其作用方式.
主要方法:
- 细菌RNAP抑制剂的表征 (CBR703系列).
- 测量RNAP催化活动的测试 (核酸添加, pyrophosphorolysis, Gre-刺激的转录切割).
- 在RNAP中对CBR703抗性突变的分析.
主要成果:
- CBR703化合物抑制了核酸添加,酸化和Gre刺激的转录切割.
- 这些抑制剂在脱离催化时不会影响RNA/DNA转位.
- 抵抗突变映射到与活性部位相对的RNAP表面,通过桥链连接.
结论:
- CBR703 抑制剂为RNAP核酸添加周期提供了洞察力.
- 这些化合物可能具有全性作用,阻碍催化过程中必不可少的活性部位运动.
相关概念视频
Types of RNA
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...


